Your browser doesn't support javascript.
loading
Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer.
Wang, Jingxuan; Zhang, Xiao; Shi, Jinming; Cao, Paul; Wan, Meimei; Zhang, Qiang; Wang, Yunxuan; Kridel, Steven J; Liu, Wennuan; Xu, Jianfeng; Zhang, Qingyuan; Sui, Guangchao.
Afiliação
  • Wang J; Department of Medical Oncology, the Third Affiliated Hospital of Harbin Medical University, Harbin P. R. China.
  • Zhang X; Department of Cancer Biology and Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Shi J; College of Life Science, Northeast Forestry University, Harbin, China.
  • Cao P; College of Life Science, Northeast Forestry University, Harbin, China.
  • Wan M; Department of Cancer Biology and Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Zhang Q; Department of Cancer Biology and Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Wang Y; Department of Cancer Biology and Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Kridel SJ; Department of Medical Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin P. R. China.
  • Liu W; Department of Cancer Biology and Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Xu J; Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Zhang Q; Department of Cancer Biology and Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Sui G; Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Oncotarget ; 7(48): 78566-78576, 2016 Nov 29.
Article em En | MEDLINE | ID: mdl-27713175
ABSTRACT
Fatty acid synthase (FASN) is upregulated in breast cancer and correlates with poor prognosis. FASN contributes to mammary oncogenesis and serves as a bona fide target in cancer therapies. MicroRNAs inhibit gene expression through blocking mRNA translation or promoting mRNA degradation by targeting their 3'-UTRs. We identified four microRNAs in two microRNA clusters miR-15a-16-1 and miR-497-195 that share a common seed sequence to target the 3'-UTR of the FASN mRNA. In reporter assays, both of these microRNA clusters inhibited the expression of a reporter construct containing the FASN 3'-UTR. However, only ectopic miR-15a-16-1, but not miR-497-195, markedly reduced the levels of endogenous FASN in breast cancer cells. Both miR-15a and miR-16-1 contributes to inhibiting FASN expression and breast cancer cell proliferation. Consistently, a sponge construct consisting of eight repeats of the FASN 3'-UTR region targeted by these microRNAs could markedly increase endogenous FASN levels in mammary cells. When FASN expression was restored by ectopic expression in breast cancer cells, retarded cell proliferation caused by miR-15a-16-1 was partially rescued. In conclusion, we demonstrated that FASN expression is primarily downregulated by miR-15a and miR-16-1 in mammary cells and FASN is one of the major targets of these two tumor suppressive microRNAs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / MicroRNAs / Ácido Graxo Sintase Tipo I Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / MicroRNAs / Ácido Graxo Sintase Tipo I Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article